Revenue Recognition - Disaggregation of Revenue (Details) - Revenue from Contract with Customer Benchmark - Product Concentration Risk	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cell Engineering
Disaggregation of Revenue [Line Items]
Concentration risk	100.00%	100.00%	100.00%	100.00%
Pharma and biotech
Disaggregation of Revenue [Line Items]
Concentration risk	22.00%	40.00%	25.00%	35.00%
Agriculture
Disaggregation of Revenue [Line Items]
Concentration risk	23.00%	20.00%	25.00%	23.00%
Food and nutrition
Disaggregation of Revenue [Line Items]
Concentration risk	4.00%	11.00%	10.00%	13.00%
Government and defense
Disaggregation of Revenue [Line Items]
Concentration risk	25.00%	4.00%	21.00%	5.00%
Industrial and environment
Disaggregation of Revenue [Line Items]
Concentration risk	11.00%	11.00%	10.00%	12.00%
Consumer and technology
Disaggregation of Revenue [Line Items]
Concentration risk	15.00%	14.00%	9.00%	12.00%